期刊文献+

曲安奈德对家免视网膜的病理组织学的影响

Retinal Changes of Intravitreal Triamcinolone Acetonide: a Pathohistological Study
下载PDF
导出
摘要 目的比较研究进口及国产不同剂量曲安奈德(TA)玻璃体内注射对家兔视网膜组织形态学的影响.方法家兔24只,分为6组:A组;B组;C组;D组;E组和F组.除A组外所有动物行右眼玻璃体切除术后注射曲安奈德(IVTA)1次,给药后观察21d,取眼球,行病理学检查.结果除A组外,其它各组可见节细胞轻度水肿.E组和F组部分动物见内或外颗粒层细胞增生,细胞内空泡.E组和F组各有1只动物见玻璃体腔内、视网膜与脉络膜之间大量红染纤维素样物质.E组和F组病变重于C组和D组.结论IVTA 25mg引起家兔眼感光细胞增生,IVTA10 mg无明显改变.进口与国产的TA对家兔视网膜的影响无明显差别. Objective To investigate the effect of triamcinolone acetonide (TA) with different dosage and place of production on retina. MethOdS Twenty-four rabbits were divided into 6 groups (A: untreated as a blank control; B: normal sodium; C: 10mg imported TA; D: 10 mg domestic-made TA; E: 25 mg imported TA; F: 25 mg domestic-made TA) , Excepting group A every fight eyeball underwent vitrectomy before intravitreal injection triamcinolone acetonide, All the eyeballs were extirpated on the 21st day after the intravitreal injection, and then pathological examinations were performed. Results Ganglion cell' s light edemata had been seen in group B, C, D, E, F. Cell hyperplasia and vacuolar degeneration had been seen in the internal granular layer or external granular layer in some animals of group E, F. Two samples (1 in group E, 1 in group F) observed there were a great amount of fibrinoid materials in cavum vitreum and cavum between amphiblestroid membrane and choroid membrane. Pathological changes in group E, F were severer than in group C, D. Conclusions Intravitreous injection TA at 25 mg can cause photoreceptor cells hyporplasia in rabbits, while there are no toxic effects at 10 mg. No obvious difference is observed between the groups of imported TA and domestic-made TA.
出处 《昆明医学院学报》 2007年第6期49-52,57,共5页 Journal of Kunming Medical College
关键词 曲安奈德 毒性 视网膜 Triamcinolone acetonide Toxicity Retina
  • 相关文献

参考文献10

  • 1HABIB M S, CANNON P S, STEEL D H. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract [J]. BMC Ophthalmol, 2005, 5:15-18
  • 2BANDELLO F, POGNUZ D R, PIRRACCHIO A, et al. Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy [J]. Graefes Arch Clin Exp Ophthalmol, 2004, 242 (12): 1024-1027
  • 3刘武,王景昭.玻璃体内注射曲安奈德的问题与并发症[J].中华眼底病杂志,2005,21(4):267-270. 被引量:39
  • 4MICELLI FERRARI T, SBORGIA L, FURINO C, et al. Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema [ J ]. Eur J Ophthalmol, 2004, 14 (4): 321-324
  • 5JAGER R D, AIELLO L P, PATEL S C, et al. Risks of intravitreous injection: a comprehensive review [J ]. Retina, 2004, 24 (5): 676-698
  • 6AMATO J E, LEE D H, SANTOS B A, et al. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient [J ]. Ocul Immunol Inflamm, 2005, 13 (3): 245-247
  • 7王凯,姜燕荣,黎晓新.曲安奈德玻璃体内注射对视网膜的影响[J].中华眼底病杂志,2005,21(4):229-232. 被引量:9
  • 8MCGEE D H, DEMBINSKA O, GRUEBBEL M M. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits [J]. Int J Toxicol, 2005, 24 (6): 419-425
  • 9YUSY, DAMICO F M, VIOLA F, et al. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study [J]. Retina, 2006, 26 (5): 531-536
  • 10MOSHFEGHI D M, KAISER P K, ScoTr I U, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection [J]. Am J Ophthalmol, 2003, 136 (5) : 791-796

二级参考文献46

  • 1Jager RD, Aiello LP, Patel SP, et al. Risks of intravitreous injection: a comprehensive review. Retina, 2004,24: 676-698.
  • 2Rycroft B. Penicillin and the control of deep intraocular infection.Br J Ophthalmol, 1945,29:57-87.
  • 3Yamashita T, Doi N, Sakamoto T. Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol, 2004,242: 679-681.
  • 4Sakamoto T, Enaida H, Kubota T, et al. Incidence of acute endophthalmitis after t riamcinolone-assisted Pars Plana Vitrectomy. Am J Ophthalmol, 2004,138:137-138.
  • 5Forster RK, Zachary IG, Cottingham AJ, et al. Further observations on the diagnosis, cause, and treatment of endophthalmitis. Am J Ophthalmol, 1976,81: 52-56.
  • 6Penfold PL, Gyory JF, Hunyor AB, et al. Exudative macular degeneration and intravitreal triamcinolone:a pilot study. Aust N ZJ Ophthalmol, 1995,23:293-298.
  • 7Ip MS, Gottlieb JL, Kahana A, et al. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol, 2004,122:1131-1136.
  • 8Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema:preliminary results of a prospective controlled trial.Ophthalmology, 2004,111: 218-224.
  • 9Jonas JB, Harder B, Kamppeter BA. Inter-eye difference in diabetic macular edema after unilateral intravitreal injection of triamcinolone acetonide. Am J Ophthalmol, 2004,138: 970-977.
  • 10Audren F, Tod M, Massin P, et al. Pharmacokineticpharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci, 2004,45:3435-3441.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部